What is the share price of Krsnaa Diagnostics Ltd (KRSNAA) today?
The share price of KRSNAA as on 23rd March 2026 is ₹579.85. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Krsnaa Diagnostics Ltd (KRSNAA) share?
The past returns of Krsnaa Diagnostics Ltd (KRSNAA) share are- Past 1 week: -4.08%
- Past 1 month: -8.74%
- Past 3 months: -18.26%
- Past 6 months: -31.54%
- Past 1 year: -27.28%
- Past 3 years: 47.69%
- Past 5 years: -40.46%
What are the peers or stocks similar to Krsnaa Diagnostics Ltd (KRSNAA)?
The peers or stocks similar to Krsnaa Diagnostics Ltd (KRSNAA) include:What is the dividend yield % of Krsnaa Diagnostics Ltd (KRSNAA) share?
The current dividend yield of Krsnaa Diagnostics Ltd (KRSNAA) is 0.46.What is the market cap of Krsnaa Diagnostics Ltd (KRSNAA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Krsnaa Diagnostics Ltd (KRSNAA) is ₹1930.43 Cr as of 23rd March 2026.What is the 52 week high and low of Krsnaa Diagnostics Ltd (KRSNAA) share?
The 52-week high of Krsnaa Diagnostics Ltd (KRSNAA) is ₹894.40 and the 52-week low is ₹579.15.What is the PE and PB ratio of Krsnaa Diagnostics Ltd (KRSNAA) stock?
The P/E (price-to-earnings) ratio of Krsnaa Diagnostics Ltd (KRSNAA) is 24.87. The P/B (price-to-book) ratio is 2.19.Which sector does Krsnaa Diagnostics Ltd (KRSNAA) belong to?
Krsnaa Diagnostics Ltd (KRSNAA) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.How to buy Krsnaa Diagnostics Ltd (KRSNAA) shares?
You can directly buy Krsnaa Diagnostics Ltd (KRSNAA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Krsnaa Diagnostics Ltd
KRSNAA Share Price
NSE₹579.851.33% (-7.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
KRSNAA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
KRSNAA Performance & Key Metrics
KRSNAA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 24.02 | 2.19 | 0.46% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 35.10 | 5.54 | 0.61% |
100%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
KRSNAA Company Profile
The Company provides diagnostic services. It provides radiology and pathology services for X-rays, CT scan, magnetic resonance imaging (MRI), mammography, tele reporting X-ray and all types of blood and urine investigations.
APOLLOHOSP
PE Ratio
72.12
72.12
1Y Return
13.75%
13.75%
Buy Reco %
86.21
86.21
MAXHEALTH
PE Ratio
86.21
86.21
1Y Return
15.06%
15.06%
Buy Reco %
81.82
81.82
FORTIS
PE Ratio
79.80
79.80
1Y Return
31.04%
31.04%
Buy Reco %
82.35
82.35
PE Ratio
42.37
42.37
1Y Return
1.99%
1.99%
Buy Reco %
80.00
80.00
ASTERDM
PE Ratio
6.12
6.12
1Y Return
44.64%
44.64%
Buy Reco %
100.00
100.00
KRSNAA Sentiment Analysis
KRSNAA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
KRSNAA Stock Summary · February 2026
Krsnaa Diagnostics is strategically focused on long-term growth and sustainability within the Indian healthcare sector, emphasizing a unique operational model that leverages public-private partnerships to enhance access to affordable diagnostics. Despite facing operational challenges, including seasonality and project delays, the company has maintained positive financial metrics, with a strong EBITDA margin and optimistic revenue projections, particularly from the Rajasthan project. The shift from a predominantly B2B model to a more consumer-focused approach reflects a commitment to adapting to market demands, while ongoing investments in technology and quality assurance bolster its competitive position. Management remains confident in future growth, driven by expanding service offerings and improved receivables management, positioning Krsnaa for significant market opportunities ahead.
KRSNAA Stock Growth Drivers
KRSNAA Stock Growth Drivers
9Strong Operational Network
Krsnaa Diagnostics has established an extensive integrated diagnostic network across 18 states and union territories,
Financial Resilience
The company has maintained positive EBITDA and PAT since its inception, reflecting the resilience and
KRSNAA Stock Challenges
KRSNAA Stock Challenges
5Decline in B2B Segment Performance
The company has experienced a significant decline in its B2B segment of retail, with revenue
Concerns Over Order Wins and Revenue Impact
There are concerns regarding the lack of major order wins over the past year, particularly
KRSNAA Forecast
KRSNAA Forecasts
Price
Revenue
Earnings
KRSNAA Share Price Forecast
KRSNAA Share Price Forecast
2026
Current
₹587.65
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹587.65
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
KRSNAA Company Revenue Forecast
KRSNAA Company Revenue Forecast
2025
Current
₹749.17
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹749.17
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
KRSNAA Stock EPS (Earnings Per Share) Forecast
KRSNAA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹24.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹24.04
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
KRSNAA
KRSNAA
Income
Balance Sheet
Cash Flow
Quarterly Normal View
KRSNAA Income Statement
KRSNAA Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 159.61 | 162.40 | 170.62 | 177.55 | 190.93 | 183.75 | 190.46 | 196.94 | 210.17 | 184.97 | ||||||||||
Operating & Other expenses | 123.66 | 120.93 | 122.58 | 127.56 | 136.94 | 129.44 | 133.09 | 141.58 | 146.84 | 134.84 | ||||||||||
EBITDA | 35.95 | 41.47 | 48.04 | 49.99 | 53.99 | 54.31 | 57.37 | 55.36 | 63.33 | 50.13 | ||||||||||
| Depreciation/Amortization | 19.46 | 21.23 | 18.12 | 21.47 | 22.20 | 22.70 | 21.96 | 21.63 | 23.59 | 22.66 | ||||||||||
| PBIT | 16.49 | 20.24 | 29.92 | 28.52 | 31.79 | 31.61 | 35.41 | 33.73 | 39.74 | 27.47 | ||||||||||
| Interest & Other Items | 3.06 | 4.15 | 7.32 | 5.32 | 6.39 | 6.13 | 6.81 | 6.30 | 8.19 | 7.79 | ||||||||||
| PBT | 13.43 | 16.09 | 22.60 | 23.20 | 25.40 | 25.48 | 28.60 | 27.43 | 31.55 | 19.68 | ||||||||||
| Taxes & Other Items | 2.93 | 3.13 | 3.88 | 5.29 | 5.81 | 6.07 | 7.93 | 6.90 | 7.62 | 4.44 | ||||||||||
| Net Income | 10.50 | 12.96 | 18.72 | 17.91 | 19.59 | 19.41 | 20.67 | 20.53 | 23.93 | 15.24 | ||||||||||
| EPS | 3.35 | 4.09 | 5.80 | 5.55 | 6.07 | 6.01 | 6.40 | 6.35 | 7.38 | 4.72 |
KRSNAA Company Updates
FY 2026FY 2026
Investor Presentation
Feb 5PDF
Nov 7PDF
Aug 11PDF
KRSNAA Stock Peers
KRSNAA Past Performance & Peer Comparison
KRSNAA Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHospitals & Diagnostic Centres
Compare valuation on Screener
Health CareHospitals & Diagnostic Centres
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Krsnaa Diagnostics Ltd | 24.87 | 2.19 | 0.46% |
| Apollo Hospitals Enterprise Ltd | 72.12 | 9.40 | 0.17% |
| Max Healthcare Institute Ltd | 86.21 | 9.89 | 0.16% |
| Fortis Healthcare Ltd | 79.80 | 6.74 | 0.12% |
KRSNAA Stock Price Comparison
Compare KRSNAA with any stock or ETFCompare KRSNAA with any stock or ETF
KRSNAA
KRSNAA Holdings
KRSNAA Shareholdings
KRSNAA Promoter Holdings Trend
KRSNAA Promoter Holdings Trend
KRSNAA Institutional Holdings Trend
KRSNAA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
KRSNAA Shareholding Pattern
KRSNAA Shareholding Pattern
KRSNAA Shareholding History
KRSNAA Shareholding History
Foreign Institutions
Mutual Funds Invested in KRSNAA
Mutual Funds Invested in KRSNAA
No mutual funds holding trends are available
Top 5 Mutual Funds holding Krsnaa Diagnostics Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 8.5852% | Percentage of the fund’s portfolio invested in the stock 1.55% | Change in the portfolio weight of the stock over the last 3 months -0.28% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 29/66 (-9) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 2.0902% | Percentage of the fund’s portfolio invested in the stock 0.20% | Change in the portfolio weight of the stock over the last 3 months -0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 78/259 (-9) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.1620% | Percentage of the fund’s portfolio invested in the stock 1.73% | Change in the portfolio weight of the stock over the last 3 months -1.25% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 36/44 (-26) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing KRSNAA stock
smallcases containing KRSNAA stock
Looks like this stock is not in any smallcase yet.
KRSNAA Events
KRSNAA Events
KRSNAA Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
KRSNAA Dividend Trend
No dividend trend available
KRSNAA Upcoming Dividends
KRSNAA Upcoming Dividends
No upcoming dividends are available
KRSNAA Past Dividends
KRSNAA Past Dividends
Cash Dividend
Ex DateEx DateSep 12, 2025
Final
Final | Div/Share: ₹2.75
Dividend/Share
₹2.75
Ex DateEx Date
Sep 12, 2025
Cash Dividend
Ex DateEx DateSep 13, 2024
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 13, 2024
Cash Dividend
Ex DateEx DateSep 15, 2023
Final
Final | Div/Share: ₹2.75
Dividend/Share
₹2.75
Ex DateEx Date
Sep 15, 2023
Cash Dividend
Ex DateEx DateSep 15, 2022
Final
Final | Div/Share: ₹2.50
Dividend/Share
₹2.50
Ex DateEx Date
Sep 15, 2022
KRSNAA Stock News & Opinions
KRSNAA Stock News & Opinions
Articles & Videos
Earnings
Krsnaa Diagnostics consolidated net profit declines 21.47% in the December 2025 quarter
Net profit of Krsnaa Diagnostics declined 21.47% to Rs 15.25 crore in the quarter ended December 2025 as against Rs 19.42 crore during the previous quarter ended December 2024. Sales rose 3.83% to Rs 181.20 crore in the quarter ended December 2025 as against Rs 174.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales181.20174.51 4 OPM %25.5825.83 - PBDT42.3448.18 -12 PBT19.6825.48 -23 NP15.2519.42 -21 Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Krsnaa Diagnostics standalone net profit declines 23.66% in the December 2025 quarter
Net profit of Krsnaa Diagnostics declined 23.66% to Rs 16.49 crore in the quarter ended December 2025 as against Rs 21.60 crore during the previous quarter ended December 2024. Sales declined 3.47% to Rs 159.43 crore in the quarter ended December 2025 as against Rs 165.16 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales159.43165.16 -3 OPM %29.9029.00 - PBDT43.7551.06 -14 PBT21.2228.37 -25 NP16.4921.60 -24 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Krsnaa Diagnostics schedules board meeting
Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 5 February 2026.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Krsnaa Diagnostics schedules board meeting
Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 12 December 2025.Powered by Capital Market - Live
3 months agoCapital Market - Live
Earnings
Krsnaa Diagnostics consolidated net profit rises 22.19% in the September 2025 quarter
Net profit of Krsnaa Diagnostics rose 22.19% to Rs 23.95 crore in the quarter ended September 2025 as against Rs 19.60 crore during the previous quarter ended September 2024. Sales rose 10.55% to Rs 205.99 crore in the quarter ended September 2025 as against Rs 186.34 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales205.99186.34 11 OPM %28.7226.51 - PBDT55.1547.61 16 PBT31.5625.40 24 NP23.9519.60 22 Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Krsnaa Diagnostics to table results
Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 7 November 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Krsnaa Diagnostics schedules AGM
Krsnaa Diagnostics announced that the Annual General Meeting(AGM) of the company will be held on 25 September 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Krsnaa Diagnostics consolidated net profit rises 14.51% in the June 2025 quarter
Net profit of Krsnaa Diagnostics rose 14.51% to Rs 20.52 crore in the quarter ended June 2025 as against Rs 17.92 crore during the previous quarter ended June 2024. Sales rose 13.36% to Rs 192.98 crore in the quarter ended June 2025 as against Rs 170.23 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales192.98170.23 13 OPM %26.6325.06 - PBDT49.0544.67 10 PBT27.4223.20 18 NP20.5217.92 15 Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Krsnaa Diagnostics to convene board meeting
Krsnaa Diagnostics will hold a meeting of the Board of Directors of the Company on 11 August 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Corporate
Board of Krsnaa Diagnostics recommends final dividend
Krsnaa Diagnostics announced that the Board of Directors of the Company at its meeting held on 12 May 2025, inter alia, have recommended the final dividend of Rs 2.75 per equity Share (i.e. 55%) , subject to the approval of the shareholders.Powered by Capital Market - Live
10 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant